title: Attenuation of cardiac but not vascular component in baroreflex of spontaneously hypertensive rats.
abstract: The cardiac and vascular components of the baroreceptor reflex in spontaneously hypertensive rat (SHR) and stroke-prone spontaneously hypertensive rat (SHRSP) were compared against their counterparts in normotensive Wistar Kyoto rat (WKY). SHR, SHRSP and WKY of 12-16 weeks old were chronically instrumented for intra-arterial recording of blood pressure. Intravenous injections of phenylephrine and nitroprusside were used to challenge their baroreflex. The products of blood pressure change and the half time required for the pressure to return to the control value were used as the quantitative estimation of the blood pressure stabilizing capability. The cardiac component of the baroreflex was obtained from the change in the blood pressure stabilizing capability after blockade of beta and muscarinic receptors by atenolol and atropine, respectively. The vascular component was obtained by subtracting the cardiac component from the total stabilizing capability which was the difference after blockade with a ganglionic transmission blocker, hexamethonium. We found the cardiac component of the baroreflex of the hypertensive rats was significantly less sensitive than that of the WKY. In contrast, the vascular component of the baroreflex of the three strains did not differ significantly. Therefore, we concluded that the 12-16 week old SHRs were able to maintain a stable blood pressure due to the intact vascular component of the baroreflex.
authors.affiliation: Institute of Zoology, National Taiwan University, Taipei, ROC.
authors.forename: C J
authors.initials: CJ
authors.lastname: Han
authors.forename: M L
authors.initials: ML
authors.lastname: Tsai
authors.forename: R F
authors.initials: RF
authors.lastname: Chen
authors.forename: C Y
authors.initials: CY
authors.lastname: Chai
authors.forename: C T
authors.initials: CT
authors.lastname: Yen
mesh_terms: D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D001285:Atropine / Q000494:pharmacology; D017704:Baroreflex / Q000502:physiology*; D001794:Blood Pressure / Q000187:drug effects; D001808:Blood Vessels / Q000503:physiopathology*; D005730:Ganglionic Blockers / Q000494:pharmacology; D006321:Heart / Q000503:physiopathology*; D006339:Heart Rate / Q000187:drug effects; D018738:Hexamethonium / Q000494:pharmacology; D006973:Hypertension / Q000235:genetics / Q000503:physiopathology*; D008297:Male; D009599:Nitroprusside / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY
chemical_list: D000316:Adrenergic alpha-Agonists; D000959:Antihypertensive Agents; D005730:Ganglionic Blockers; D010276:Parasympatholytics; D009599:Nitroprusside; D010656:Phenylephrine; D018738:Hexamethonium; D001285:Atropine